Adonis raises $40M in Series C

Adonis, an AI-driven platform specializing in revenue cycle management (RCM) for healthcare organizations, has secured $40 million in a Series C funding round led by Quadrille Capital. This financial injection aims to enhance the company's market position by addressing the increasing complexities healthcare providers face due to rising claim denial rates and evolving reimbursement processes.

The latest funding round boosts Adonis’s total raised capital to over $95 million since its inception in 2022. The company’s technology offers an advanced approach to revenue cycle management, leveraging AI to detect and resolve issues proactively, thereby minimizing revenue losses for hospitals and health systems like Mount Sinai. Adonis's platform demonstrates its effectiveness through significant metrics, including a more than four-fold increase in revenue in 2025 and a net retention rate exceeding 130%, evidencing its capability to deliver tangible operational improvements rather than speculative benefits.

Adonis was founded with the intent to equip healthcare providers with the advanced tools that insurers have long utilized to manage claims more effectively. The firm offers a proactive alternative to traditional RCM methods, which have been criticized for their reactivity and inefficiency, costing providers dearly. By adopting a human-in-the-loop model, Adonis ensures accountability and governance, thus promoting confidence in adopting AI technologies among healthcare finance teams.

The healthcare tech sector has witnessed a surge in demand for innovative solutions as providers struggle to cope with increasingly sophisticated payer strategies and policy changes affecting coverage and reimbursement. The funding for Adonis reflects broader market dynamics where tech-enabled healthcare solutions tackle structural inefficiencies, offering strategic advantages in a competitive landscape. As healthcare systems seek to optimize financial operations and mitigate losses from denied claims, firms like Adonis stand to benefit significantly.

Looking forward, the infusion of new capital will likely support Adonis in scaling its operations and expanding its market reach. There are no immediate regulatory concerns reported, but the successful deployment of its AI solutions across broader markets could set precedent models for efficiency in healthcare financial management. Subsequent milestones may involve further technological integrations or partnerships focused on expanding Adonis's footprint in the healthcare RCM domain.